| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 16.95× | 16.95× | 12.82× | 10.53× | 3.79× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.10× | 0.10× | 0.15× | 0.14× | 0.64× | ||
| 0.96× | 0.96× | −0.17× | −0.12× | −1.72× | ||
| 0.51× | 0.51× | −0.11× | −0.07× | −1.17× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 3.79 | 10.53 | 12.82 | 16.95 | 16.95 | |
| Asset Turnover | 0.64 | 0.14 | 0.15 | 0.10 | 0.10 | |
| Cash Conversion (CFO/Net Income) | -1.72 | -0.12 | -0.17 | 0.96 | 0.96 | |
| CFO/EBITDA | -1.17 | -0.07 | -0.11 | 0.51 | 0.51 |